Costa P. Erectile dysfunction: knowledge, wishes and attitudes. Results of a French study of 5099 men aged 17 to 70. P. Costa, Avances, L. Prog. Urol., 2003, 13: 85-91.
McVary KT. Erectile dysfunction. New Engl. J. Med., 2007, 357: 2472-81.
Vardi Y, Bulus M, Reisner S et al. Effects of sildenafil citrate (Viagra) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with erectile dysfunction and cardiovascular disease. European Urology, 2003, 43: 544-51.
Feldman HA., Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J. Urology, 1994, 151: 54-61.
Гамидов С.И. Исследование эндотелиальной функции кавернозных артерий в диагностике артериогенной эректильной дисфункции. С.И. Гамидов, В.В. Иремашвили. Андрология и гени-тальная хирургия, 2006, 4: 25-30.
Глыбочко П.В., Аляев Ю.Г., Есилевский Ю.М. и соавт. Выбор препаратов ингибиторов фос-фодиэстеразы 5-го типа для лечения больных эректильной дисфункцией и хроническим простатитом. Сеченовский вестник, 2013, 2: 33-40.
Briganti A, Gallina A, Suardi N, Capitanio U, Tutolo M, Bianchi M, Passoni N, Salonia A, Colombo R, Di Girolamo V, Guazzoni G, Rigatti P Montorsi P. Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: A proposal of a novel preoperative risk stratification. J Sex Med, 2010, 7: 2521-31.
Feneley MR, Carruthers M. Is testosterone treatment good for the prostate? Study of safety during long-term treatment. J Sex Med., 2012, 9: 2138-49.
Локшин К.Л. Сравнительная характеристика силденафила и других ингибиторов фосфо-диэстеразы 5-го типа в лечении больных эрек-тильной дисфункцией (обзор литературы). Русский медицинский журнал, 2013, 18: 936-939.
Вагнер Г., Грин Р. Импотенция. Физиология, психология, хирургия, диагностика и лечение. Пер. с англ. М.: Медицина, 1985: 240.
Beutel ME. Epidemiology of sexual dysfunction in the male population. M.E. Beutel, W. Weidner, E. Brahler. Andrologia, 2006, 38(4): 115-121.
Mann K, Pankok J, Connemann B et al. Sleep investigations in erectile dysfunction. J. Psychiatr. Res., 2005, 39: 93-9.
Reffelmann T, Kloner RA. Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease. Circulation, 2003, 15: 239-44.
Diabetes and sexual function in older adults: results of an international survey / A. Nicolosi [etal.] // Br. J. Diabetes Vase. Dis., 2002, 2: 336339.
Seftel AD. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. A.D. Seftel, P. Sun, R. Swindle. J. Urol. (Baltimore), 2004, 171(6): 2341-2345.
Berthet J, Sutherland EW, Rall TW. The assay of glucagon and epinephrine with use of liver homogenates. J. Biol. Chem., 1957, 229(1): 351-61.
Desouza C, Akers D, Parulkar A, Fonseca VA, Lumpkin D. Acute and prolonged effects of sildenafil on brachial artery flow mediated dilatation in type 2 diabetes. Diabetes Care, 2002, 25(8): 336-9.
Lee AJ, Chiao TB, Tsang MP. Sildenafil for Pulmonary Hypertension. Ann Pharmacother, 2005, 39(5): 869-84.
Rosengarten B, Schermuly RT, Voswinckel R et al. Sildenafil improves dynamic vascu-lar function in the brain: studies in patients with pulmonary hypertension. Cerebrovasc Dis., 2006, 21(3): 194-200.
Chua R, Keogh A, Miyashita M. Novel use of sildenafil in the treatment of portopulmon-ary hypertension. J Heart Lung Transplant, 2005, 24(4): 498-500.